1. Home
  2. FULC vs CAL Comparison

FULC vs CAL Comparison

Compare FULC & CAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Fulcrum Therapeutics Inc.

FULC

Fulcrum Therapeutics Inc.

HOLD

Current Price

$3.64

Market Cap

467.8M

Sector

Health Care

ML Signal

HOLD

Logo Caleres Inc.

CAL

Caleres Inc.

HOLD

Current Price

$13.14

Market Cap

400.3M

ML Signal

HOLD

Company Overview

Basic Information
Metric
FULC
CAL
Founded
2015
1878
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Shoe Manufacturing
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
467.8M
400.3M
IPO Year
2019
1994

Fundamental Metrics

Financial Performance
Metric
FULC
CAL
Price
$3.64
$13.14
Analyst Decision
Buy
Buy
Analyst Count
8
2
Target Price
$16.38
$15.00
AVG Volume (30 Days)
4.2M
660.5K
Earning Date
04-27-2026
05-28-2026
Dividend Yield
N/A
2.13%
EPS Growth
N/A
N/A
EPS
N/A
0.42
Revenue
N/A
$85,513,000.00
Revenue This Year
N/A
$5.19
Revenue Next Year
N/A
$2.45
P/E Ratio
N/A
$30.93
Revenue Growth
N/A
0.46
52 Week Low
$2.83
$8.80
52 Week High
$15.74
$16.14

Technical Indicators

Market Signals
Indicator
FULC
CAL
Relative Strength Index (RSI) 32.75 48.03
Support Level $2.83 $11.85
Resistance Level $8.18 $13.97
Average True Range (ATR) 0.27 1.01
MACD 0.02 -0.15
Stochastic Oscillator 20.76 33.83

Price Performance

Historical Comparison
FULC
CAL

About FULC Fulcrum Therapeutics Inc.

Fulcrum Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing small molecules for genetically defined rare diseases. Its product candidate, Pociredir, is an oral small molecule designed to induce fetal hemoglobin (HbF) and is in clinical development for sickle cell disease (SCD). The company completed dosing in the Phase 1b PIONEER trial evaluating pociredir in adults with SCD and reported clinical data showing clinically relevant HbF induction and improvements in markers of hemolysis and anemia. The company has also generated a pipeline of clinical-stage and pre-clinical programs targeting the root causes of rare genetic diseases.

About CAL Caleres Inc.

Caleres Inc is a footwear company that operates retail shoe stores and e-commerce websites, and designs, develops, sources, manufactures, and distributes footwear for people of all ages. The Company's business operations are organized into two reportable segments - famous Footwear and Brand Portfolio. The famous Footwear segment is comprised of its famous Footwear retail stores, famousfootwear.com, and famousfootwear.ca. The famous Footwear segment operated around 846 stores at the end of 2024. The Brand Portfolio segment offers retailers and consumers a cultivated portfolio of known brands. Geographically, the company generates the majority of its revenue from Domestic operations.

Share on Social Networks: